ASP

DRUG4 trials

Sponsors

PETHEMA Foundation, Menzies School of Health Research, Vastra Gotaland Region, London School of Hygiene and Tropical Medicine

Conditions

Acute Lymphoblastic LeukemiaCovid-19MalariaPharyngitisPharyngitis BacterialSore ThroatStreptococcus PharyngitisTonsillitis

Phase 3

Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia

London School of Hygiene and Tropical MedicineCovid-19

Start: 2021-01-22End: 2022-07-31Target: 1200Updated: 2021-06-04

Phase 4

Treatment of High Risk Adult Acute Lymphoblastic Leukemia

CompletedNCT00853008

PETHEMA FoundationAcute Lymphoblastic Leukemia

Start: 2003-01-31End: 2012-12-31Target: 100Updated: 2020-04-07

A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the Sudan

CompletedNCT02592408

Menzies School of Health ResearchMalaria

Start: 2015-11-30End: 2016-05-31Updated: 2017-02-01

Unknown Phase

Antimicrobial Stewardship Program (ASP) in Patients With a Sore Throat

CompletedNCT03408704

Vastra Gotaland RegionPharyngitis, Pharyngitis Bacterial, Sore Throat +2

Start: 2018-01-17End: 2022-02-28Updated: 2022-06-06

Related Papers

Prevention and treatment for COVID-19 associated severe pneumonia in the Gambia (PaTS-COVID-19), a single-blinded randomized clinical trial: study protocol

International Journal of Clinical Trials2023-01-23

Outcome of Adults with Relapsed T-Cell Acute Lymphoblastic Leukemia (T-ALL) Included in Minimal Residual Disease (MRD)-Oriented Trials

Blood2020-11-04

Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols

Blood2018-11-29

Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan

Malaria Journal2018-03-1618 citations